Brief: Mink Therapeutics Provides Corporate Update And Reports Fourth Quarter Results
18/03/2022 13:34
March 18 (Reuters) - Mink Therapeutics Inc INKT.O :
* MINK THERAPEUTICS PROVIDES CORPORATE UPDATE AND REPORTS
FOURTH
QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS
* Q4 LOSS PER SHARE $0.18 INCLUDING ITEMS
* CASH BALANCE AT DECEMBER 31, 2021 IS $39 MILLION,
REFLECTING NET
PROCEEDS RECEIVED FROM OUR IPO DURING Q4
Source text for Eikon: ID:nGNX1cJp4G
Further company coverage: INKT.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Mink Therapeutics
See all newsMiNK Therapeutics Q2 loss narrows on expense discipline
Brief: MiNK Therapeutics Q2 EPS USD -0.62
Mink Therapeutics Inc expected to post a loss of 60 cents a share - Earnings Preview
Brief: MiNK Therapeutics Says No Major Serious Adverse Events Attributed To Agent-797 In First Patients
U.S. STOCKS ON THE MOVE-Snowflake, Best Buy, Kohl's